| # | Drug | Count |
|---|---|---|
| 0 | DUPILUMAB | 47 |
| 1 | TREPROSTINIL | 27 |
| 2 | FLUTICASONE PROPIONATE | 26 |
| 3 | ALBUTEROL SULFATE | 19 |
| 4 | SOMATROPIN | 14 |
| 5 | MINOXIDIL | 11 |
| 6 | MINOXIDIL FOAM 5% (WOMENS) | 11 |
| 7 | ADALIMUMAB | 10 |
| 8 | CRISABOROLE | 9 |
| 9 | ERGOCALCIFEROL | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE AND MAGNESIUM CHLORIDE | 1 | 0.0169 |
| 1 | NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE | 2 | 0.0076 |
| 2 | OXICONAZOLE NITRATE | 1 | 0.0058 |
| 3 | FIRST AID ANTIBIOTIC | 1 | 0.0042 |
| 4 | LANOLIN, PETROLATUM | 1 | 0.0040 |
| 5 | AVOBENZONE, HOMOSALATE, OCTISALATE, AND OCTOCRYLENE | 1 | 0.0039 |
| 6 | DILUENT | 4 | 0.0039 |
| 7 | GLYCOPYRRONIUM | 6 | 0.0039 |
| 8 | LANOLIN AND PETROLATUM | 1 | 0.0038 |
| 9 | FLUOROMETHOLONE ACETATE | 1 | 0.0037 |
| # | Drug class | Count |
|---|---|---|
| 0 | Interleukin-4 Receptor alpha Antagonist [EPC] | 47 |
| 1 | Prostacycline Vasodilator [EPC] | 27 |
| 2 | Insulin Analog [EPC] | 22 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 14 |
| 4 | GLP-1 Receptor Agonist [EPC] | 13 |
| 5 | 5-alpha Reductase Inhibitor [EPC] | 12 |
| 6 | Arteriolar Vasodilator [EPC] | 12 |
| 7 | Phosphodiesterase 4 Inhibitor [EPC] | 10 |
| 8 | Benzodiazepine [EPC] | 9 |
| 9 | Corticosteroid [EPC] | 9 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 3 | 0.0044 |
| 1 | Skin Test Antigen [EPC] | 6 | 0.0032 |
| 2 | Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] | 5 | 0.0028 |
| 3 | Pyrethroid [EPC] | 1 | 0.0006 |
| 4 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 5 | Sulfonamide Antibacterial [EPC] | 2 | 0.0005 |
| 6 | PCSK9 Inhibitor [EPC] | 9 | 0.0003 |
| 7 | Plasma Volume Expander [EPC] | 1 | 0.0003 |
| 8 | Provitamin D2 Compound [EPC] | 9 | 0.0003 |
| 9 | Antiparasitic [EPC] | 1 | 0.0002 |